ESMFold2 vs AlphaFold3

Do not write "ESMFold2 is better than AlphaFold3" as a blanket fact. The accurate wording is that Biohub reports selected evaluation results and efficiency claims in its own release materials.

A comparison page should link official sources, explain the claim, and avoid inventing benchmark numbers.

For users, the immediate difference is workflow. ESMFold2 is tied to Biohub's open code and model-weight release, official notebooks, and API examples. AlphaFold3 has its own access model and usage constraints.

This page is designed to help users decide which official path to read next, not to make clinical or drug-development conclusions.

The MVP can compare source availability, example coverage, input preparation, API ergonomics, output files, and confidence interpretation. It should not claim wet-lab accuracy or therapeutic utility.

A safe comparison can cover how users access each system, what official examples are available, whether code and weights are linked publicly, how outputs are inspected, and which confidence artifacts are exposed in examples.

Those dimensions are useful to developers and researchers without pretending to run an independent benchmark. They also answer practical search intent better than a vague "which is better" article.

The page should not invent accuracy percentages, clinical value, drug discovery success rates, or wet-lab validation claims. If the page mentions antibody-antigen binding pose prediction, it should attribute the claim to Biohub or the linked source that reports it.

The page should also avoid implying that AlphaFold3 and ESMFold2 are interchangeable services. Their access paths, examples, licensing constraints, and intended workflows may differ, and users should check the official sources for each system.

If the user wants to learn ESMFold2 specifically, they should use the Biohub, GitHub, API, and code generator pages on this site. If they need a formal benchmark decision, they should read primary sources rather than treating an SEO comparison page as the benchmark.

For production or lab-facing work, predicted structures should still be treated as computational outputs that require careful review and experimental validation where appropriate.

The page should compare workflow questions before performance slogans: where each model is documented, how a user starts, what example inputs are available, what output artifacts users inspect, and what policy boundaries affect use.

That structure is better for search intent because most visitors are trying to decide what to read or run next. They may not have enough context to interpret benchmark language, but they can understand whether they need a notebook, API example, local install, or official platform documentation.

When the page is expanded into a full comparison table, every row should have a source or a clear limitation note. Unsupported rows should stay out of the page until they can be verified.

This is also the page where future benchmark updates should be added only after the exact dataset, source, and claim language are available.

This launch page is written as a third-party guide, not as an official Biohub page. It links to Biohub, GitHub, Colab, model-card, paper, and reporting sources so readers can verify current details before copying code or making technical decisions.

The free Track A site does not collect protein sequences, private Biohub tokens, prediction outputs, or uploaded structure files. Browser-local tools can prepare starter code and examples, but hosted prediction, stored results, queues, and credits remain Phase 2 features.

Predicted structures should not be described as experimental validation, clinical evidence, or drug-development proof. When this page mentions model scope or comparisons, it keeps claims tied to official or clearly attributed sources.

If a source changes after this page is published, the source should win. The page should be updated with a new verification date instead of preserving stale client names, model IDs, pricing assumptions, or unsupported benchmark language.